User:Iluvicedtea/sandbox/ledgerwood

From Wikipedia, the free encyclopedia

Julie E. Ledgerwood
Alma materPhillips University
College of Osteopathic Medicine at Oklahoma State University’s Center for Health Sciences
Known forChief of the Clinical Trials Program at NIAID
Led the first human trial to test the Ebola vaccine
Scientific career
Fields
InstitutionsNational Institute of Allergy and Infectious Diseases

Julie E. Ledgerwood is a board-certified allergist and immunologist and serves as Chief of the Clinical Trials Program at the Vaccine Research Center (VRC) of the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health in Bethesda, Maryland. She is a Doctor of osteopathic medicine.[1]

Dr. Ledgerwood leads clinical trials and clinical collaborations for the VRC; and has served as Principal Investigator, Protocol Chair, or Associate Investigator for over 35 Phase I and II IND clinical trials studying vaccines and monoclonal antibodies targeting HIV, influenza, Ebola, malaria, Chikungunya, and other emerging infectious diseases. She led the first human trial aimed at testing a vaccine for Ebola virus.[2]

Education[edit]

Dr. Ledgerwood graduated from Phillips University in Enid, Oklahoma and received her doctor of osteopathic medicine diploma from the College of Osteopathic Medicine at Oklahoma State University’s Center for Health Sciences.[1]

Career[edit]

From 1999-2002, Dr. Ledgerwood completed her medical residency in internal medicine at Johns Hopkins Bayview Medical Center in Baltimore, Maryland. In 2002, Dr. Ledgerwood joined NIAID as a clinical fellow in allergy and immunology. In 2003, she joined the VRC as a clinical investigator. Dr. Ledgerwood is by the American Board of Allergy and Immunology.[1]

Her work has been covered extensively in lay and scientific media outlets, including NBC News, Politico[3], The Guardian[4], NPR[5], and The New York Times.[6]


Additional Sources[edit]

NIH[edit]

News Coverage[edit]

Ebola[edit]

Chikungunya[edit]

Today, http://www.medicalnewstoday.com/articles/281062.php

Marburg Virus[edit]

References[edit]

  1. ^ a b c "Julie Ledgerwood, D.O., Clinical Trials, Vaccine Research Center". www.niaid.nih.gov. Retrieved 2016-03-09.
  2. ^ "First Human Ebola Vaccine Trial Shows It Seems to Work - NBC News". NBC News. Retrieved 2016-03-09.
  3. ^ "How to Eradicate Political Panic". POLITICO Magazine. Retrieved 2016-03-09.
  4. ^ "Nigeria: Trial Confirms Ebola Vaccine Candidate Safe". allAfrica.com. Retrieved 2016-03-09.
  5. ^ "Experimental Vaccine For Chikungunya Passes First Test". NPR.org. Retrieved 2016-03-09.
  6. ^ Grady, Denise (2009-12-21). "Case of Marburg Fever Puzzles Scientists". The New York Times. ISSN 0362-4331. Retrieved 2016-03-09.